Archil Jaliashvili: Hemopure and the Future of Oxygen Delivery in Severe Bleeding
Archil Jaliashvili, Co-owner, General Manager of SkinAI, Co-Chief Executive Officer at GeoBio Pharm, shared a post on LinkedIn:
”A patient with catastrophic hemorrhage survived after Cleveland Clinic used Hemopure, when conventional blood transfusion was not an option.
For decades, we spoke about ‘blood substitutes.’
But the real medical target was never blood itself.
The target is oxygen delivery.
We should not only manage hemoglobin numbers.
We must manage tissue oxygenation.
The future of transfusion medicine will not be only about blood.
It will be about precision oxygen delivery.
For emerging BHOC biological hemoglobin oxygen carrier biosimilar and new-generation platforms, this is another important real-world signal that the field is evolving toward solving major global unmet medical needs:
- Severe hemorrhage
- Trauma and emergency care
- Battlefield medicine
- Maternal bleeding
- Organ preservation and perfusion
- Veterinary critical care
- Remote and disaster medicine
Sometimes one clinical case says more than a thousand theoretical discussions.”
Stay updated with Hemostasis Today.
-
May 20, 2026, 15:37Tareq Abadl։ Hemolysis in Blood Bags and Its Dangers in Transfusion
-
May 20, 2026, 15:27Kalyan Roy: Thalassaemia and the Importance of Early Screening
-
May 20, 2026, 15:11Adelard Kakunze: Changing the Future of Sickle Cell Disease in Africa
-
May 20, 2026, 15:00William Aird: When Oxygen Becomes the Limiting Factor
-
May 20, 2026, 14:58Gloria Duah: Regular Voluntary Blood Donation Remains One of the Most Powerful Acts of Humanity in Healthcare
-
May 20, 2026, 14:55David Ferreira: When Thrombophilia Becomes a Decision-Making Challenge
-
May 20, 2026, 14:19Highlighting Women With Bleeding Disorders at the European DIU Programme – EHC
-
May 20, 2026, 14:16Sebastian Szmit: New Real-World Analysis on Atrial Fibrillation in Myeloproliferative Neoplasms
-
May 20, 2026, 14:15Caitlin Raymond: Did You Know Kcentra Is Plasma-Derived?